Shire’s New Drugs Defence to AbbVie - Presented by: The Aol. On Network

The fight back is on - the pharmaceutical group Shire is adopting tried and tested tactics to fend off AbbVie. The US firm is offering $46 billion for the British company. Shire says it's not enough and has a promising range of drugs to prove it. It says its current products will generate sales of at least $7 billion by 2020 with $3bln coming from drugs in the pipeline. It's also a serial acquirer - and has benefitted from six deals in the past 13 months.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
GILD $ 94.3051 14.14 ▼ 13.04%
RAD $ 7.1699 0.40 ▲ 5.91%
ACHN $ 15.65 1.44 ▲ 10.13%
PBR $ 7.49 0.38 ▲ 5.34%
BAC $ 17.695 0.08 ▲ 0.43%
QQQ $ 104.429 0.11 ▲ 0.10%
S $ 4.205 0.05 ▲ 1.08%
AAPL $ 112.505 0.73 ▲ 0.65%

As of 12/22/2014, 02:49 PM
More Most Active